Aridis Pharma COVID-19 Antibody Neutralizes Omicron Variant In Animal Study
Aridis Pharmaceuticals Inc's (NASDAQ: ARDS) fully human monoclonal antibodies (mAbs) in the
Benzinga ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
THE TRUTH ABOUT: Aridis pharmaceuticals inc org - Caught on Camera
How Is The Market Feeling About Aridis Pharmaceuticals Inc?
Aridis Pharmaceuticals Inc's (NASDAQ:ARDS) short percent of float has risen 3350.0% since last its last report. The company recently reported that it has 130.40 thousand shares sold short, which is 1.38% of all regular shares that are available for trading.
Benzinga ·
(ARDS) - Analyzing Aridis Pharmaceuticals Inc's Short Interest
Aridis Pharmaceuticals Inc's (NASDAQ:ARDS) short percent of float has risen 3350.0% since last its last report. The company recently reported that it has 130.40 thousand shares sold short, which is 1.38% of all regular shares that are available for trading.
Benzinga ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
(ARDS) - Analyzing Aridis Pharmaceuticals Inc's Short Interest
Aridis Pharmaceuticals Inc's (NASDAQ:ARDS) short percent of float has risen 3350.0% since last its last report. The company recently reported that it has 130.40 thousand shares sold short, which is 1.38% of all regular shares that are available for trading.
Benzinga ·
Looking Into Aridis Pharmaceuticals Inc's Recent Short Interest
Aridis Pharmaceuticals Inc's (NASDAQ:ARDS) short percent of float has risen 3350.0% since last its last report. The company recently reported that it has 130.40 thousand shares sold short, which is 1.38% of all regular shares that are available for trading.
Benzinga ·
Coverage From
Benzinga
Topics
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
